Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Coustans

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
La Revue Du Praticien|December 22, 1999
[Evolution and surveillance of multiple sclerosis]G Edan, M Coustans
Pathologie-Biologie|May 18, 2000
[Is immunosuppression a future therapeutic strategy for multiple sclerosis?]G Edan, M Coustans
Acta Neurochirurgica|December 21, 2006
Spontaneous resolution of arachnoid cysts: review and features of an unusual caseR Seizeur, P Forlodou, M Coustans, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2012
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational studyE Leray, M Coustans, E Le Page, et al.
Revue Neurologique|March 7, 2006
[Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients]E Le Page, E Leray, G Taurin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2007
Long-term survival of patients with multiple sclerosis in West FranceE Leray, S P Morrissey, J Yaouanq, et al.
Revue Neurologique|October 2, 2021
Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trialM Michel, E Le Page, D A Laplaud, et al.
Journal of the Neurological Sciences|June 14, 2011
Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patientsA Kerbrat, E Le Page, E Leray, et al.
Journal of Neurology|July 29, 2018
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patientsG Balloy, J Pelletier, L Suchet, et al.
Neurology|April 13, 2005
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severityR H S R Roxburgh, S R Seaman, T Masterman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
La Revue Du Praticien|December 22, 1999
[Evolution and surveillance of multiple sclerosis]G Edan, M Coustans
Pathologie-Biologie|May 18, 2000
[Is immunosuppression a future therapeutic strategy for multiple sclerosis?]G Edan, M Coustans
Acta Neurochirurgica|December 21, 2006
Spontaneous resolution of arachnoid cysts: review and features of an unusual caseR Seizeur, P Forlodou, M Coustans, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2012
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational studyE Leray, M Coustans, E Le Page, et al.
Revue Neurologique|March 7, 2006
[Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients]E Le Page, E Leray, G Taurin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2007
Long-term survival of patients with multiple sclerosis in West FranceE Leray, S P Morrissey, J Yaouanq, et al.
Revue Neurologique|October 2, 2021
Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trialM Michel, E Le Page, D A Laplaud, et al.
Journal of the Neurological Sciences|June 14, 2011
Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patientsA Kerbrat, E Le Page, E Leray, et al.
Journal of Neurology|July 29, 2018
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patientsG Balloy, J Pelletier, L Suchet, et al.
Neurology|April 13, 2005
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severityR H S R Roxburgh, S R Seaman, T Masterman, et al.
Pageof 1